Nelson Advisors - Thought Leadership

top of page

Nelson Advisors > European Healthcare Technology Investment Banking

Analysis of the MyFitnessPal Acquisition of Cal AI

Analysis of the MyFitnessPal Acquisition of Cal AI

Strategic Consolidation of Digital Nutrition: Analysis of the MyFitnessPal Acquisition of Cal AI

Nelson Advisors

Mar 4

Do we have a Dunning-Kruger effect problem in healthcare AI

Do we have a Dunning-Kruger effect problem in healthcare AI

Do we have a Dunning Kruger effect problem in healthcare AI?

Nelson Advisors

Mar 3

The Exit Factor: Why M&A is on the rise in HealthTech - Nelson Advisors HLTH Europe 2026

The Exit Factor: Why M&A is on the rise in HealthTech - Nelson Advisors HLTH Europe 2026

The Exit Factor: Why M&A is on the rise in HealthTech - Nelson Advisors HLTH Europe 2026

Nelson Advisors

Mar 3

Healthcare AI’s evolution from the "Scribe Wars" toward the "Clinician AI stack"

Healthcare AI’s evolution from the "Scribe Wars" toward the "Clinician AI stack"

Healthcare AI’s evolution from the "Scribe Wars" toward the "Clinician AI stack"

Nelson Advisors

Mar 1

Assessing the Viability of the Third-Party Portal Market Amidst the Expansion of the NHS App

Assessing the Viability of the Third-Party Portal Market Amidst the Expansion of the NHS App

The Strategic Consolidation of Patient Engagement: Assessing the Viability of the Third Party Portal Market Amidst the Expansion of the NHS App

Nelson Advisors

Feb 28

HealthTech HALO Effect: Heavy Assets, Low Obsolescence in the Healthcare AI Era

HealthTech HALO Effect: Heavy Assets, Low Obsolescence in the Healthcare AI Era

HealthTech HALO Effect: Heavy Assets, Low Obsolescence in the Healthcare AI Era

Nelson Advisors

Feb 28

Analysis of OpenEvidence’s AI Integrated Telehealth Ecosystem

Analysis of OpenEvidence’s AI Integrated Telehealth Ecosystem

The Convergence of Clinical Intelligence and Patient Outreach: Analysis of OpenEvidence’s AI Integrated Telehealth Ecosystem

Nelson Advisors

Feb 28

Strategic Realignment of European AI Governance: Analysis of AI Omnibus Proposal and Impact on EU AI Act

Strategic Realignment of European AI Governance: Analysis of AI Omnibus Proposal and Impact on EU AI Act

Strategic Realignment of European AI Governance: Analysis of AI Omnibus Proposal and Impact on EU AI Act

Nelson Advisors

Feb 27

This Week in European MedTech and HealthTech: 27th February 2026

This Week in European MedTech and HealthTech: 27th February 2026

This Week in European MedTech and HealthTech: 27th February 2026

Nelson Advisors

Feb 27

Healthcare Business International interviews Nelson Advisors discussing the Hims & Hers acquisition of Eucalyptus

Healthcare Business International interviews Nelson Advisors discussing the Hims & Hers acquisition of Eucalyptus

Healthcare Business International interviews Nelson Advisors discussing the Hims & Hers acquisition of Eucalyptus

Nelson Advisors

Feb 26

2026 Software Sell-Off and AI Valuation Correction in Healthcare Technology and MedTech

2026 Software Sell-Off and AI Valuation Correction in Healthcare Technology and MedTech

How could the Software sell off and AI bubble in early 2026 affect Digital Health, HealthTech and MedTech funding and M&A for the rest of 2026?

Nelson Advisors

Feb 26

Strategic Evolution of European Healthcare Investment Banking

Strategic Evolution of European Healthcare Investment Banking

The Strategic Evolution of European Healthcare Investment Banking: A Definitive Analysis of Nelson Advisors and the Specialised Boutique Ascendancy

Nelson Advisors

Feb 26

FemTech's transition into a pillar of Global Healthcare Acquisition strategies

FemTech's transition into a pillar of Global Healthcare Acquisition strategies

FemTech's transition from fragmented Venture Capital category into Women’s Health and pillar of Global Healthcare Acquisition strategies

Nelson Advisors

Feb 25

2026 Biopharmaceutical M&A Renaissance

2026 Biopharmaceutical M&A Renaissance

The 2026 Biopharmaceutical M&A Renaissance: Strategic Consolidation Amidst Patent Volatility and Technological Convergence

Nelson Advisors

Feb 25

Every Cure and Computational Pharmacophenomics: A New Field of Medicine

Every Cure and Computational Pharmacophenomics: A New Field of Medicine

Every Cure and Computational Pharmacophenomics: A New Field of Medicine

Nelson Advisors

Feb 24

Doctolib's Potential 3 Year Strategic Outlook

Doctolib's Potential 3 Year Strategic Outlook

Doctolib's Potential 3 Year Strategic Outlook 2026 to 2028: IPO, AI and International Expansion

Nelson Advisors

Feb 23

Founder Bankers and Taxonomy of European Healthcare Technology Investment Banking Specialists

Founder Bankers and Taxonomy of European Healthcare Technology Investment Banking Specialists

Founder Bankers and Taxonomy of European Healthcare Technology Investment Banking Specialists

Nelson Advisors

Feb 21

Future Billion Dollar HealthTech and MedTech Sectors

Future Billion Dollar HealthTech and MedTech Sectors

Future Billion Dollar HealthTech and MedTech Sectors

Nelson Advisors

Feb 20

This Week in European MedTech and HealthTech: 20th February 2026

This Week in European MedTech and HealthTech: 20th February 2026

This Week in European MedTech and HealthTech: 20th February 2026

Nelson Advisors

Feb 20

Analysis of the $1.15 Billion Acquisition of Eucalyptus by Hims & Hers Health

Analysis of the $1.15 Billion Acquisition of Eucalyptus by Hims & Hers Health

Global Health Convergence: Analysis of the $1.15 Billion Acquisition of Eucalyptus by Hims & Hers Health

Nelson Advisors

Feb 20

bottom of page